In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4536-4541

  Seiler, Peter ^a,b   Senn, Beatrice M ^a   Bründler, Marie Anne ^a,c   Zinkernagel, Rolf M ^a   Hengartner, Hans ^a   Kalinke, Ulrich ^a,d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE ACTIVATION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMBRANE BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CARRIER; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

EID: 0033561552     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Weigle, W. O. 1961. The immune response of rabbits tolerant to bovine serum albumin to the injection of other heterologous serum albumins. J. Exp. Med. 114:111.
2. Chiller, J. M., G. S. Habicht, and W. O. Weigle. 1971. Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science 171:813.
3. Nemazee, D. A., and K. Bürki, 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562.
4. Russell, D. M., Z. Dembic, G. Morahan, J. F. A. P. Miller, K. Bürki, and D. Nemazee. 1991. Peripheral deletion of self-reactive B cells. Nature 354:308.
5. Hartley, S. B., J. Crosbie, R. Brink, A. B. Kantor, A. Basten, and C. C. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353:765.
6. Brombacher, F., G. Kohler, and H. Eibel. 1991. B cell tolerance in mice transgenic for anti-CD8 immunoglobulin mu chain. J. Exp. Med. 174:1335.
7. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, G. S. Smith, R. A. Brink, B. H. Pritchard, J. S. Wotherspoon, R. H. Loblay, K. Raphael, R. J. Trent, and A. Basten. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676.
8. Pewzner-Jung, Y., D. Friedmann, E. Sonoda, S. Jung, K. Rajewsky, and D. Eilat. 1998. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. J. Immunol. 161:4634.
9. Erikson, J., M. Z. Radic, S. A. Camper, R. R. Hardy, C. Carmack, and M. Weigert. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349:331.
10. Bachmann, M. F., R. U. Hoffmann, T. M. Kündig, K. Bürki, H. Hengartner, and R. M. Zinkernagel. 1993. The influence of antigen organisation on B cell responsiveness. Science 262:1448.
11. Traub, E. 1936. An epidemic in a mouse colony due to the virus of acute lymphocytic choriomeningitis. J. Exp. Med. 63:533.
12. Traub, E. 1936. Persistence of lymphocytic choriomeningitis virus in immune animals and its relation to immunity. J. Exp. Med. 63:847.
13. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1.
14. Buchmeier, M. J., R. M. Welsh, F. J. Dutko, and M. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275.
15. Oldstone, M. B. A., and M. J. Buchmeier. 1982. Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature 300:360.
16. Buchmeier, M. J., and M. B. A. Oldstone. 1978. Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection. J. Immunol. 120:1297.
17. Oxenius, A., M. F. Bachmann, R. M. Zinkernagel, and H. Hengartner. 1998. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28:390.
18. Pircher, H. P., K. Bürki, R. Lang, H. Hengartner, and R. M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342:559.
19. + T cells upon acute versus persistent viral infection. Immunity 9:449.
20. Thomsen, R. A., M. Volkert, and O. Marker. 1985. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice. Immunology 55:213.
21. Seiler, P., U. Kalinke, T. Rülicke, E. M. Bucher, C. Böse, R. M. Zinkernagel, and H. Hengartner. 1998. Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus neutralizing antibodies in immunoglobulin transgenic mice. J. Virol. 72:2253.
22. Bruns, M., J. Cihak, G. Müller, and F. Lehmann-Grube. 1983. Lymphocytic choriomeningitis virus. V1. Isolation of a glycoprotein mediating neutralization. Virology 130:247.
23. Seiler, P., M.-A. Bründler, C. Zimmermann, D. Weibel, M. Bruns, H. Hengartner, and R. M. Zinkernagel. 1998. Induction of protective cytotoxic T cell responses in the presence of high titers of virus neutralizing antibodies: implications for passive and active immunization. J. Exp. Med. 187:649.
24. Battegay, M., S. Cooper, A. Althage, J. Baenziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods 33:191.
25. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
26. Romanowski, V., Y. Matsuura, and D. H. L. Bishop. 1985. Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus. Virus Res. 3:101.
27. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94:6874.
28. Parekh, B. S., and M. J. Buchmeier. 1986. Proteins of lymphocytic choriomeningitis virus: Antigenic topography of the viral glycoproteins. Virology 153:168.
29. Kalinke, U., E. M. Bucher, B. Ernst, A. Oxenius, H.-P. Roost, S. Geley, R. Kofler, R. Zinkernagel, and H. Hengartner. 1996. The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. Immunity 5:1.
30. Wisnewski, A., L. Cavacini, and M. Posner. 1996. Human antibody variable region gene usage in HIV-1 infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 11:31.
31. Köhler, H., S. Müller, and P. L. Nara. 1994. Deceptive imprinting in the immune response against HIV-1. Immunol. Today 15:475.
32. Müller, S., H. Wang, G. J. Silverman, G. Bramlet, N. Haigwood, and H. Köhler. 1993. B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV-1 infection. Scand. J. Immunol. 38:327.
33. Grimaldi, L. M., R. P. Roos, S. G. Devare, W. G. Robey, J. M. Casey, M. E. Gurney, B. R. Apatoff, and D. Lazzarin. 1988. Restricted heterogeneity of antibody to gp 120 and p 24 in AIDS. J. Immunol. 141:114.
34. Amadori, A., P. Gallo, R. Zamarchi, M. L. Veronese, A. DeRossi, D. Wolf, and L. Chieco-Bianchi. 1990. IgG oligoclonal bands in sera of HIV-1 infected patients are mainly directed against HIV-1 determinants. AIDS Res. Hum. Retroviruses 6:581.
35. D'Amelio, R., R. Biselli, R. Nisini, P. M. Matricardi, A. Aiuti, I. Mezzaroma, E. Pinter, O. Ponteselli, and F. Aiuti. 1992. Spectrotype of anti-gp 120 antibodies remains stable during the course of HIV disease. J. Acquired Immune Defic. Syndr. 5:930.
36. Berberian, L., L. Goodglick, T. J. Kipps, and J. Braun. 1993. Immunoglobulin VH3 gene products: natural ligands for HIV gp 120. Science 261:1588.
37. Adderson, E. E., P. G. Shackelford, A. Quinn, and W. L. Carroll. 1991. Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J. Immunol. 147:1667.
38. Adderson, E. E., P. G. Shackelford, R. A. Insel, A. Quinn, P. M. Wilson, and W. L. Carrol. 1992. Immungloblulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of Vκ and Vλ segments and VJ combinations. J. Clin. Invest. 89:729.
39. Adderson, E. E., P. G. Shackelford, A. Quinn, P. M. Wilson, M. W. Cunningham, R. A. Insel, and W. L. Carroll. 1993. Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b capsular polysaccharide. J. Clin. Invest. 91:2734.
40. Schroeder, H. W. j., J. L. Hillson, and R. M. Perlmutter. 1987. Early restriction of the human antibody repertoire. Science 238:791.
41. Hartley, S. B., M. P. Cooke, D. A. Fulcher, A. W. Harris, S. Cory, A. Basten, and C. C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72:325.
42. Fulcher, D. A., and A. Basten. 1994. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J. Exp. Med. 179:125.
43. Fazekas de StGroth, S. 1981. The Joint Evolution of Antigens and Antibodies. S. Karger, Basel. Vol. 2, p. 155.
44. Fazekas de StGroth, S., and R. G. Webster. 1966. Disquistions on original antigenic sin. II. Proof in lower creatures. J. Exp. Med. 124:347.
45. Fish, S., E. Zenowich, M. Fleming, and T. Manser. 1989. Molecular analysis of original antigenic sin. I. Clonal selection, somatic mutation, and isotype switching during a memory B cell response. J. Exp. Med. 170:1191.
46. Fazekas de StGroth, S., and R. G. Webster. 1966. Disquisitions on original antigenic sin. I. Evidence in man. J. Exp. Med. 124:331.
47. Gerhard, W., J. Yewdell, and M. E. Frankel. 1981. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290:713.
48. Weiss, R. A., P. R. Clapham, J. N. Weber, A. G. Dalgleish, L. A. Lasky, and P. W. Berman. 1986. Variable and conserved neutralization antigens of human immunodeficiency virus. Nature 324:572.
49. Ping, L. H., and S. M. Lemon. 1992. Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J. Virol. 66:2208.
50. Parry, N., G. Fox, D. Rowlands, F. Brown, E. Fry, D. Logan, and D. Stuart. 1990. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth-disease virus. Nature 347:569.
51. Kilbourne, E. D. 1977. Influenza pandemics in perspective. JAMA 237:1225.
52. Davenport, F. M., E. Minuse, A. V. Hennessy, and T. Francis, Jr. 1969. Interpretations of influenza antibody patterns of man. Bull. W.H.O. 41:453.
53. Albert, J., B. Abrahamsson, K. Nagy, E. Aurelius, H. Gaines, G. Nystrom, and E. M. Fenyo. 1990. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4:107.
54. Nowak, M. A., R. M. Anderson, A. R. McLean, T. F. W. Wolfs, J. Goudsmit, and R. M. May. 1991. Antigenic diversity thresholds and the development of AIDS. Science 254:963.